Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis

Published:2022-02-04 Issue:1 Volume:54 Page:516-523
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Wen Wen¹²,Chen Chen¹²,Tang Jiake¹²,Wang Chunyi¹²,Zhou Mengyun³,Cheng Yongran⁴,Zhou Xiang¹,Wu Qi¹,Zhang Xingwei¹,Feng Zhanhui⁵^ORCID,Wang Mingwei¹^ORCID,Mao Qin¹

Affiliation:

1. Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou, PR China

2. Hangzhou Normal University, Hangzhou, PR China

3. Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto, Japan

4. School of Public Health, Hangzhou Medical College, Hangzhou, PR China

5. Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, PR China

Funder

Hangzhou Science and Technology Bureau fund

Youth Fund of Zhejiang Academy of Medical Sciences

Medical and Technology Project of Zhejiang Province

Clinical Research Fund of Zhejiang Medical Association

Hangzhou Health and Family Planning Technology Plan Key Projects

Hangzhou Medical and Health Technology Project

Zhejiang Traditional Chinese Medicine Scientific Research Fund Project

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2034936

Reference33 articles.

1. WHO. Coronavirus (COVID-19) data. [cited 2021 Nov 12]. Available from: https://www.who.int/data#reports

2. Course and Lethality of SARS-CoV-2 Epidemic in Nursing Homes after Vaccination in Florence, Italy

3. National health commission of the people's republic of China. [cited 2021 Nov 12]. Available from: http://www.nhc.gov.cn/jkj/s7915/202111/fc017abab2af4dfbbe5b4f0bdcbf8795.shtml

4. Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

5. CDC Interim Recommendations for Fully Vaccinated People

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of antiviral phytochemicals from cranberry as potential inhibitors of SARS-CoV-2 main protease (Mpro);International Journal of Biological Macromolecules;2024-03

2. The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19;Pharmaceutics;2024-02-02

3. A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients;Journal of Herbal Medicine;2024-02

4. Virology and safety profile of Molnupiravir at three different doses for treatment of SARS‐CoV‐2: a systematic review and meta‐analysis;APMIS;2024-01-30

5. Clinico-economic analysis of COVID-19 etiotropic pharmacotherapy;Journal of Volgograd State Medical University;2024-01-27